Predictors of Unfavourable Treatment Outcome in Patients With Multidrug-Resistant Tuberculosis in India

Public Health Action- France

doi 10.5588/pha.16.0055

Full Text

Abstract

Available in

Date

Authors

Publisher

International Union Against Tuberculosis and Lung Disease

Related search

Factors Affecting Time to Sputum Culture Conversion and Treatment Outcome of Patients With Multidrug-Resistant Tuberculosis in China

BMC Infectious Diseases
Infectious Diseases
2018English

Health System Delay in Treatment of Multidrug Resistant Tuberculosis Patients in Bangladesh

BMC Infectious Diseases
Infectious Diseases
2015English

Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Patients

Korean Journal of Internal Medicine
Internal Medicine
2019English

Hepatotoxicity During Treatment for Multidrug-Resistant Tuberculosis: Occurrence, Management and Outcome

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2012English

Impact of Diabetes Mellitus on Treatment Outcome of Multidrug Resistant Pulmonary Tuberculosis

Journal of Evolution of Medical and Dental Sciences
2018English

Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis

The Lancet
Medicine
2018English

Glycated Haemoglobin Levels in Patients With Multidrug-Resistant Tuberculosis Infection During 6 Months of Treatment

African Journal of Clinical and Experimental Microbiology
2016English

Comparison of the Validity of Smear and Culture Conversion as a Prognostic Marker of Treatment Outcome in Patients With Multidrug-Resistant Tuberculosis

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy